ABSTRACT
The history of drug formulations that rely on nanoengineering is quite modern. The launch of products incorporating nanostructure particles is showing clear differentiation across sectors. Materials and products based on nanotechnology are regulated today within the existing network. Nanostructures are evaluated as “chemicals with new uses” or as “new chemicals.”
